The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Gene Therapy Review
City of Edinburgh, United Kingdom
A
1-10 Employees
2008
Key takeaway
The Gene Therapy Review is a leading resource for information on in vivo gene therapy, detailing the process of transferring genetic material to dysfunctional cells to correct deficiencies in a patient's DNA. This site, established in 2007, serves as a comprehensive hub for the life sciences research community.
Highlighted product
Core business
Home | Gene Therapy Review
Innovation Hubs for Gene Therapies
London, United Kingdom
A
11-50 Employees
2021
Key takeaway
The company focuses on manufacturing essential vectors for gene therapy trials, including lentivirus and adeno-associated virus (AAV). With the potential of gene therapies to treat various conditions and a strong research base in the UK, advancements in this field are rapidly progressing towards making these therapies a standard in healthcare.
Highlighted product
Core business
Capabilities :: Innovation Hubs for Gene Therapies
Veristat
London, United Kingdom
A
251-500 Employees
1994
Key takeaway
The company has extensive experience in supporting the development and commercialization of gene therapies, having played a key role in the approval of the first gene therapy in Europe. Their expertise in clinical trial planning and execution positions them as a valuable partner for biopharmaceutical companies navigating the complexities of gene therapy development.
Highlighted product
Service
Gene Therapy: Creative Solutions for Complex Clinical Development Pathways
A full-service clinical trial CRO offering Clinical Operations services including patient recruitment, patient enrollment, patient retention, site engagement, clinical trial project management, and clinical trial monitoring services & feasibility.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Genevation LTD
Stevenage, United Kingdom
A
1-10 Employees
2022
Key takeaway
Genevation LTD is dedicated to advancing cancer treatment through innovative approaches like personalized cancer vaccines. With expertise in cancer biology and RNA biology, the company focuses on developing effective therapies that address the unique mutations in cancer cells, positioning itself as a leader in the field.
Highlighted product
Core business
Mrna Vaccine | Genevation Ltd
With years of expertise and experience, Genevation LTD is proud to be regarded as a manufacturing leader in Cancer vaccine. Every decision is inspired by our main mission, which is to save people's life.
Freeline
Stevenage, United Kingdom
A
101-250 Employees
2015
Key takeaway
Freeline is a clinical-stage biotechnology company that develops innovative adeno-associated virus (AAV)-vector-mediated systemic gene therapies, aiming to improve patient lives through transformative, one-time treatments. Their proprietary AAV platform technology is designed to deliver functional copies of therapeutic genes into liver cells, which could be particularly relevant for in vivo gene therapy applications.
Highlighted product
Core business
Freeline – changing lives by innovative gene therapies
A leading biotechnology company focused on innovative liver directed gene therapies for bleeding disorders and other debilitating, chronic diseases
Freeline
Stevenage, United Kingdom
A
51-100 Employees
2015
Key takeaway
Freeline is a clinical-stage biotechnology company focused on developing transformative adeno-associated virus (AAV)-vector-mediated systemic gene therapies. They are advancing a clinical program in Gaucher disease and exploring various targets, utilizing their proprietary AAV technology to deliver therapeutic genes directly into liver cells, aiming to provide long-lasting treatments for chronic diseases.
Highlighted product
Core business
Freeline
Ninevah Therapeutics
London, United Kingdom
A
1-10 Employees
2019
Key takeaway
The company is focused on developing an AAV-based gene therapy platform that specifically targets podocytes, highlighting their commitment to advancing gene therapy for kidney patients.
Highlighted product
Core business
bringing gene therapy to kidney patients -
bringing gene therapy to kidney patients -
Testavec
Uxbridge, United Kingdom
A
1-10 Employees
2017
Key takeaway
TestAVec focuses on enhancing the safety and confidence of gene therapy (GT) products through innovative in vitro assays that address genotoxic risks associated with viral vectors. Their patented human stem cell-based testing platform aims to reduce reliance on animal models, ultimately accelerating the development and clinical application of gene therapies.
Highlighted product
Core business
Home | Testavec
Oxford Genetics
Cherwell District, United Kingdom
A
51-100 Employees
2011
Key takeaway
OXGENE, the innovation arm of WuXi Advanced Therapies, specializes in providing advanced technology and service solutions that enhance the development and delivery of cell and gene therapies. Their expertise in viral vector optimization and seamless integration with GMP manufacturing supports pioneering companies in accelerating the transition from research to clinical manufacture, addressing challenges such as scalable AAV production for gene therapies.
Highlighted product
Core business
OXGENE
CamGenetix
Cambridge, United Kingdom
A
1-10 Employees
-
Key takeaway
Cambridge GenetiX is focused on innovative therapeutic solutions, including their advanced CAR-T cell lentivirus manufacturing services, which are essential for developing cell-based therapies. Their commitment to universal health services and groundbreaking products like Huminase highlights their dedication to improving medical outcomes, particularly in stroke management and cancer treatment.
Highlighted product
Core business
CamGenetix - CamGenetix
Technologies which have been searched by others and may be interesting for you:
When exploring the In Vivo Gene Therapy industry in the United Kingdom, several key considerations come into play. Regulatory frameworks are critical, as the UK adheres to stringent guidelines set by the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) for gene therapies. Understanding these regulations is vital for compliance and successful product development. The industry faces challenges such as high development costs, the complexity of delivery systems, and potential ethical concerns surrounding genetic modifications. However, significant opportunities exist in the UK due to its robust research environment and strong academic institutions, which foster innovation. Additionally, the competitive landscape is marked by both established pharmaceutical companies and emerging biotech firms, creating a dynamic market. Environmental concerns, particularly regarding vector safety and biological waste management, are also crucial for companies to address. The global market relevance of In Vivo Gene Therapy is growing, with increasing investments and collaborations aimed at advancing treatment options for genetic disorders. Overall, thorough research into these factors will provide valuable insights for anyone interested in this evolving field in the UK.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | United Kingdom |
| Amount of fitting manufacturers | 732 |
| Amount of suitable service providers | 559 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1994 |
| Youngest suiting company | 2022 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of In Vivo Gene Therapy?
Start-Ups who are working in In Vivo Gene Therapy are Innovation Hubs for Gene Therapies, Genevation LTD
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Healthcare, Other, Pharmaceuticals, Medical
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
